Font Size: a A A
Keyword [TERT promoter]
Result: 21 - 36 | Page: 2 of 2
21. Relationship Between BRAFV600E Gene And TERT Promoter Mutations And Cervical Lymph Node Metastasis In Papillary Thyroid Carcinoma
22. Effect And Mechanism Of Protein Kinase A Inhibitor On The Expression Of Human Telomere Reverse Transcriptase Gene In Thyroid Cancer Cells
23. BRAF Gene Mutation Based Recurrent Risk Analysis And Target Therapy Optimization In Papillary Thyroid Carcinoma
24. A Study On Relation Between BRAFV600E Mutation And TERT Promoter Mutation With Clinicopathologic Characteristics Of Papillary Thyroid Carcinoma
25. Effect Of TERT Promoter Mutation On The Polarization And Function Of Microglia/Tumour-Associated Macrophages In Primary Glioblastoma
26. Correlation Between BRAF V600E And TERT Promoter Mutations And Clinicopathological Characteristics Of Papillary Thyroid Carcinoma
27. Construction Of A Recombinant Adenovirus With Hemagglutinin-neuraminidase (HN) Gene Which Is Co-regulated By MTERT And MTyr Promoters And Its Research On Targeting Therapy Of Melanoma Cell Line B16
28. Analysis Of TERT Promoter Mutation,ATRX And PML Protein Expression And Prognosis In Secondary Glioblastoma
29. Study On The Expression And Correlation Of ATRX And TERT In Different Grades Of Glioma
30. Meta-analysis Of The Effect Of Combined BRAF And Telomerase Reverse Transcriptase Promoter Mutations On Clinicopathological Features And Prognosis Of Papillary Thyroid Cancer
31. The Value Of BRAF,TERT Gene Mutation Detection Based On Fine Needle Aspiration In Predicting The Malignant Degree Of Papillary Thyroid Carcinoma Before Operation
32. Effect Of TERT Promoter Mutation On Prognosis Of HCC Patients After Radical Resection Surgery
33. The Effect Of TERT Promoter Revertant Mutation On Melanoma Growth Inhibition And Its Mechanism
34. Serum Tg Was Used To Evaluate The Efficacy Of 131I Therapy In Differentiated Thyroid Cancer Patients With Distant Metastasis In A Series Of Studies
35. Construction Of MRI Radiomics And Deep Learning Model To Predict TERT Promoter Status In Oligodendrogliomas
36. Anlotinib Inhibits PTC Via EGFR/HSP90AB1/eEF2 Pathway In BAFV600E And TERT Promoter Mutations
  <<First  <Prev  Next>  Last>>  Jump to